This inventor holds 1 USPTO granted patent. Top assignee: Alcobra Ltd.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Johanna Schumann: Innovator in Cognitive Disorder Therapies
Introduction
Johanna Schumann is a prominent inventor based in Modiin, Israel. She has made significant contributions to the field of cognitive disorders through her innovative research and development. Her work focuses on improving therapeutic responses for individuals with Fragile X Syndrome and other cognitive disorders.
Latest Patents
Johanna holds a patent titled "Methods of determining response to therapy." This invention relates to methods for determining the response to metadoxine therapy specifically for the treatment of Fragile X Syndrome. Additionally, it identifies individuals who are likely to respond positively to metadoxine therapy. She has 1 patent to her name.
Career Highlights
Johanna Schumann has established herself as a key figure in her field. Her dedication to research and innovation has led to advancements that can significantly impact the lives of those affected by cognitive disorders. She is associated with Alcobra Ltd., a company focused on developing therapies for neurological conditions.
Collaborations
Throughout her career, Johanna has collaborated with notable professionals in her field, including Yaron Daniely and Jonathan Rubin. These collaborations have enhanced her research and contributed to the development of effective therapeutic methods.
Conclusion
Johanna Schumann's work exemplifies the importance of innovation in the treatment of cognitive disorders. Her contributions are paving the way for improved therapies and better outcomes for patients.